Orbimed Advisors - INOTEK PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2016$11,281,000
-35.7%
1,849,3000.0%0.14%
-28.0%
Q3 2016$17,531,000
+69.4%
1,849,300
+32.9%
0.20%
+85.2%
Q2 2016$10,349,000
+0.5%
1,391,0000.0%0.11%0.0%
Q1 2016$10,293,000
+113.8%
1,391,000
+227.3%
0.11%
+145.5%
Q4 2015$4,815,000
+20.5%
425,0000.0%0.04%
+10.0%
Q3 2015$3,995,000425,0000.04%
Other shareholders

There were no reported owners of INOTEK PHARMACEUTICALS CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of INOTEK PHARMACEUTICALS CORP shareholders